![]() ![]() His previous cardiologist performed an electrical cardioversion a year ago, but the patient reverted back to Afib in 40 hours. Monitoring Rate Control After CardioversionĪnother patient I recently saw for the first time has had long-standing persistent Afib. Overall, he has made 773 recordings and 677 of them were NSR, 28 unanalyzed (due to brevity), 13 unclassified and 55 showing AF. I have elected to have all non-normal, patient-recorded ECGs go into the triage tab.Īnother patient's Kardia Pro page shows that he records an ECG nearly every day, and most of the time Kardia documents NSR in the 60s. Adding new patients is a quick and simple process requiring input of patient demographics, including email and birth date.įrom the opening screen, you can click on your triage tab. It contains buttons for searching for a specific patient or adding a new patient. When I log into Kardia Pro I see this screen. This knowledge allows me to make more informed treatment decisions. The benefits of this patient being connected to me are obvious: We now have an instantaneous patient-controlled method for knowing what his cardiac rhythm is doing and whether he is having symptoms. The ECG can then be archived or exported for entry into an electronic health record. (Kardia's algorithm calls "unclassified" anything it cannot clearly identify as Afib that is over 100 BPM.) In the example below, I added atrial flutter as the diagnosis, changing it from Kardia's unclassified. In the example below, I clicked on 2/27 which has both an unclassified recording (actually atrial flutter) and an Afib recording.Ĭlicking on the ECG strips brings up the full 30-second recording on a page that also allows me to assign my formal interpretation. I can click on any of the dots and 6-second strips of the full recording are displayed. The more he used the device and got feedback on when he was in or out of rhythm, the more he was able to recognize symptoms that were caused by Afib. The display shows that, after our office visit, he maintained NSR for 3 days (green dots) and then intermittently had ECG recordings classified as Afib (yellow dots) or unclassified (black). Conclusion: Mobile ECG devices, such as AliveCor Kardia Mobile, should be evaluated for validity and accuracy as an additional modality in the diagnosis of pediatric arrhythmias.The patient overview page also displays blood pressure information if the patient is utilizing certain Omron devices that work with Kardia. As companies develop multi-lead devices and other advancements, personal ECG devices will be more accurate and may become a more integral component of arrhythmia evaluation. Mobile ECG devices are a potential option to capture arrhythmias in the pediatric population, especially those infrequent episodes that are more difficult to capture through traditional methods. The AliveCor Kardia Mobile device was able to document the infrequent tachycardia and showed findings which helped delineate the specific type of SVT. ![]() Discussion: This is a case of SVT that was unable to be documented by traditional studies, including Holter and 30-day event monitors. Greater than 1 year post ablation the patient has had no recurrence of SVT. ![]() The patient subsequently underwent successful radiofrequency ablation of the accessory pathway. An EP study was subsequently performed and revealed easily inducible orthodromic reciprocating tachycardia utilizing a left lateral concealed accessory pathway ( Figure 2). The patient subsequently bought an AliveCor Kardia Mobile device that captured a 20-minute episode of SVT with documented retrograde p waves at a heart rate of 230-250 beats per minute ( Figure 1). Over the next 2 years, she underwent 3 ECGs, a Holter monitor, a 30-day event monitor, and exercise stress testing with no arrhythmias captured. Case Description: A patient initially presented at 13 years-old due to palpitations. Supraventricular tachycardia (SVT) is the most common dysrhythmia in children. However, there is the potential for use in the pediatric population. These devices have typically been marketed for the detection of atrial fibrillation in adults. Introduction: Companies such as AliveCor have developed devices to capture cardiac rhythms and transmit the one-lead rhythm strips to smart phones. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |